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teen of the most disabling conditions as reported by the Centers for Disease Control 
were also collected. Overall work and activity impairment estimates were calculated 
for both the full sample and each of the nineteen diagnoses. Results: In total, 
50.7% of survey respondents were employed and provided information with respect 
to their work impairment; all respondents regardless of employment reported their 
activity impairment. These adults were an average 44.20 years old (SD= 13.52) and 
52.6% were male. The mean level of absenteeism, presenteeism, overall work impair-
ment, and activity impairment was 3.49%, 12.91%, 15.01%, and 22.08%, respectively 
(SDs= 13.88%, 21.98%, 24.96%, and 28.33%, respectively). The highest levels of over-
all work impairment were observed for patients with AIDS (42.7%), broken bones 
(36.6%), and hernia or rupture (32.8%) whereas the highest levels of activity impair-
ment were observed for patients with a hernia or rupture (53.9%), kidney problems 
(48.5%), and back or spine problems (47.5%). ConClusions: These results help to 
provide some context for work and activity impairment by providing estimates for 
the overall population as well as for nineteen separate disease states/conditions.
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objeCtives: The asthma quality of life questionnaire (AQLQ) is a condition-spe-
cific measure which evaluates four domains of health-related quality of life (HRQL) 
important in asthmatic adults: activity limitation, symptoms, emotional function, 
and environmental exposure. The objectives of this study were to identify: 1) How 
many HRQL claims were obtained in the label of asthma products using the AQLQ; 
2) HRQL measures used in trials but not mentioned in label; and 3) Reasons why 
to discard these measures. Methods: The PROLabels database was searched on 
12/27/2014 using “asthma” as a key word for therapeutic indication. Results: Out 
of thirty-seven products approved for asthma (five by the EMA, and 32 by the FDA), 
twenty-five had PRO claims in their label. Five of them had a HRQL claim: Symbicort 
(budesonide/formoterol fumarate dehydrate - FDA), Advair HFA (fluticasone propi-
onate/salmeterol xinafoate - FDA), Advair Diskus (fluticasone propionate/salme-
terol xinafoate - FDA), Dulera (mometasone furoate/formoterol fumarate – FDA) 
and Xolair (omalizumab - EMA). In all cases, the HRQL evaluation was performed 
using the AQLQ. Of the 20 products with PROs in label (but not HRQL), seven had 
no HRQL evaluation performed, three had no medical review available, and ten 
had a HRQL evaluation using the AQLQ (n= 8), and/or the SF-36 (n= 3) [one product 
used both measures]. The main reasons provided for not including HRQL data in 
the label were lack of statistical significance between treatment groups, or not 
reaching clinical significance. In one case (omalizumab), the FDA argued about the 
improper use of the AQLQ. ConClusions: This review has shown that all HRQL 
claims in asthma product labels were obtained using the AQLQ, a validated measure 
in asthma patients with a recognized minimally important difference enabling a 
clear interpretation of results. For these reasons the AQLQ could be considered as 
a potentially acceptable measure for regulatory qualification.
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objeCtives: To examine the relationships between health-related quality of life and 
use of Internet for health related activities among patients with asthma. Methods: 
The 2009 National Health Interview Survey and 2010 Medical Expenditure Panel 
Survey were used to select the study sample; 523 adult patients with asthma (n= 
6,075,087 weighted). Health-related quality of life was the outcome of interest. The 
Andersen Model of Health Care Utilization was used to guide the selection of inde-
pendent variables. Predisposing factors, enabling factors, need factors, smoking 
status, and health-related Internet activities comprised the independent variables. 
Five health-related Internet activities included 1) seeking health information on the 
Internet, 2) use online chat group to learn about health, 3) refill a prescription on the 
Internet, 4) schedule an appointment with a health care provider using the Internet, 
and 5) communicate with a health care provider over email. Linear regression 
analyses, incorporating the sampling weights, were employed. All analyses were 
conducted using STATA (version 13.1). Results: Fifty percent of asthma patients 
reported performing at least one health-related Internet activity. The most reported 
activity was seeking health information on the Internet (49%). Mean physical com-
ponent summary (PCS-12) and mental component summary (MCS-12) in asthma 
patients were 49.52 (SD= 0.62) and 50.5 (SD= 0.52). After controlling for independent 
variables, only scheduling an appointment with a health care provider using the 
Internet was significantly related to the physical component summary score (β = 4.94, 
95% CI: 0.95 to 8.94). ConClusions: Study Results suggest that the Internet plays a 
role in self-care and health-related quality of life among asthma patients. However, 
findings also indicate that asthma patients haven’t fully implemented using the 
Internet to accomplish all self-care tasks. Future research should examine the rela-
tionships between health-related Internet activities, health services utilization and 
outcomes.
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objeCtives: Our study was aimed to assess the Influence of Demographic 
status on outcomes such as pulmonary function, medication adherence and 
health related quality of life (HRQoL) in COPD patients Methods: An open 
which influence the treatment outcome in TB patients. ConClusions: The present 
study concluded that majority of the TB patients had successful treatment out-
come, however, efforts should be made evaluate the treatment failure particularly 
in elderly patients to achieve better treatment outcomes.
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Patients with COPD experience lower levels of health related quality of life (HRQoL). 
Social and emotional support has been found to improve mental and physical 
health and reduce mortality. Few studies have investigated the impact of social 
and emotional support among patients with COPD. objeCtives: To examine the 
impact of social and emotional support on HRQoL, disability and depression among 
COPD patients. Methods: We utilized data from the 2013 Behavioral Risk Factor 
Surveillance System (BRFSS) to match self-reported COPD patients who receive 
emotional/social support (63%) with those who rarely/never (37%) receive that sup-
port based on a propensity score model. We used the STATA command psmatch2 
to perform 1:1 nearest neighbor matching without replacement, and caliper width 
was set at 0.01. Adequacy of matching was assessed by estimating the standardized 
differences between the matched pairs for all variables. We compared the HRQoL 
domains (general, physical, mental health and activity limitation), depression and 
disability for the matched cohort using the McNemar’s test. Results: After pro-
pensity score matching, standardized differences between groups were < 10% for all 
matched variables (demographics, smoking, exercise, and comorbidities), indicat-
ing adequate matching between each level of emotional support. COPD patients 
who rarely/never receive emotional/social support were more likely to experience 
more poor physical HRQoL days (n= 307 pairs, odds ratio (OR)= 2.13, 95% confidence 
interval (CI):1.52-3.03, p< 0.001), poor mental HRQoL days (n= 300 pairs ,OR= 1.59, 
CI:1.11-2.72, p= 0.007), days of activity limitations (n= 319 pairs, OR= 1.92, CI:1.4-2.7, 
p< 0.001) and depression (n= 321 pairs, OR= 1.59, CI:1.1-2.33, p < 0.001). Poor gen-
eral health and disability were not significantly associated with emotional/social 
support. ConClusions: Among COPD patients, inadequate emotional and social 
support is associated with depression and impairments of most HRQoL domains. 
Recognition of the importance of emotional and social support by family members, 
healthcare providers and policy makers is important to improve functioning among 
COPD patients.
PRS39
humAniStic buRden of chRonic SPontAneouS uRticARiA in 
comPARiSon to PSoRiASiS: uS And euRoPeAn PeRSPective
Tian H.1, Vietri J.2, Gabriel S.1, Karagiannis T.3, Balp M.4
1Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA, 2Kantar Health, Horsham, PA, 
USA, 3Jefferson School of Population Health for Novartis Pharmaceuticals, East Hanover, NJ, USA, 
4Novartis Pharma AG, Basel, Switzerland
objeCtives: Chronic urticaria (chronic hives) can be inducible or spontaneous 
(CSU). Data supporting the impact of CSU on patients and comparisons with other 
dermatological diseases are scarce. This study evaluated the burden of illness 
associated with CSU relative to psoriasis (PsO) among adults across 5 European 
countries (EU) and the United States (US). Methods: Data from respondents with 
a diagnosis of chronic hives (as proxy for CSU) or PsO were collected from the 
National Health and Wellness Survey (NHWS) in the EU (2010-2013) and US (2010-12). 
Humanistic burden was measured using SF-12v2 (2010-11) or SF-36v2 (2012-13) and 
health utility score (SF-6D). Self-reported anxiety, depression and sleep difficulty 
were also assessed. Comorbidity was measured using Charlson Comorbidity Index 
(CCI). Bivariate analysis (t-tests for continuous and chi-square tests for categorical 
variables) was used to compare CSU patients vs. PsO patients in EU and US, respec-
tively. Results: Study included 1,516 patients with CSU (769 EU; 747 US) and 12,964 
patients with PsO (7,857 EU; 5,107 US). CSU patients had lower (worse) mean mental 
(40.8 vs. 44.6) and physical component scores (45.2 vs. 47.4) and SF-6D score (0.64 
vs. 0.69), than PsO patients (p< 0.001 for all) in EU. Lower scores for CSU patients 
were also reported in US (44.7 vs. 47.0, 43.8 vs. 45.5 and 0.67 vs. 0.70, respectively, 
p< 0.001 for all). More CSU than PsO patients reported anxiety (45.4% vs.30.4%), 
depression (26.9% vs. 20.4%) and sleep difficulties (55.7% vs. 42.6%) both in EU and 
US (41.6% vs. 30.4%, 38.8% vs. 27.7%, and 49.9% vs. 40.3%, respectively) (p< 0.001 for 
all). Comorbidity burden was higher for CSU than PsO in EU (CCI= 0.90 vs. CCI= 0.50, 
respectively) and US (CCI= 1.05 vs. CCI= 0.78) (both, p< 0.001). ConClusions: CSU 
is associated with significant detrimental impact on quality of life comparable or 
greater burden relative to PsO in EU and US.
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objeCtives: Work and activity impairment represent important dimensions for 
assessing the burden of disease. However, unlike some other patient-reported out-
come measures, there are no population norms for work and activity impairment 
or studies that extensively compare impairment across conditions. The inability 
to compare against the broader population or to specific diseases or conditions 
can make it difficult for researchers to put the effect of a disease on impairment 
in a broader context. Methods: Data came from the 2012 United States National 
Health and Wellness Survey (NHWS), a health survey of a nationally representative 
sample of adults (N= 71,141). The NHWS includes the Work Productivity and Activity 
Impairment (WPAI) questionnaire, which measures absenteeism, presenteeism, 
overall work impairment, and activity impairment. Self-reported diagnoses of nine-
